European Foundation for the Study of AMD

European Foundation for the Study of AMD
Name	European Foundation for the Study of AMD
Formation	2000s
Type	Non-profit foundation
Headquarters	Brussels, Belgium
Region served	Europe
Focus	Age-related macular degeneration research

European Foundation for the Study of AMD

The European Foundation for the Study of AMD is a Brussels-based non-profit organization devoted to advancing research, clinical practice, and public awareness of age-related macular degeneration. It engages with institutions across Europe including research centers in Paris, Berlin, London, Rome, and Amsterdam, and works with major medical societies and patient advocacy groups to translate scientific advances into policy and clinical guidelines.

History

Founded in the early 2000s amid growing interest in retinal disease, the Foundation emerged during a period when groups such as the European Union research networks, the World Health Organization, and national academies in France, Germany, United Kingdom, Italy, and Netherlands were prioritizing age-related conditions. Early collaborations included clinicians from the Moorfields Eye Hospital, investigators at the Institut Pasteur, and academic units at Charité – Universitätsmedizin Berlin. The Foundation organized symposia that paralleled meetings of the European Society of Retina Specialists and linked with projects funded under the Horizon 2020 framework and earlier FP6 programs. Its archives record interactions with regulatory bodies such as the European Medicines Agency and research funders like the Wellcome Trust and European Research Council.

Mission and Objectives

The Foundation's mission centers on reducing vision loss from age-related macular degeneration through research support, clinician training, and public engagement. Objectives include fostering translational science between laboratories at institutions like Karolinska Institutet, University of Oxford, and University of Cambridge; informing clinical practice informed by guidelines from bodies such as the Royal College of Ophthalmologists and the European Society of Cardiology (in comorbidity contexts); and promoting patient-centered care with partners such as Macular Society and the European Patient Forum. Strategic goals align with priorities of the National Institute for Health and Care Research and reference standards used by the International Council of Ophthalmology.

Research and Programs

The Foundation funds basic, translational, and clinical research projects investigating pathophysiology, imaging, and therapeutics for macular degeneration. Grants have supported molecular studies at laboratories affiliated with University of Oxford, Karolinska Institutet, University College London, and the University of Freiburg. Multicenter clinical studies coordinated with hospitals like Hospital Clínic de Barcelona and Hospital San Raffaele examined anti-VEGF therapies alongside imaging modalities developed at centers such as Massachusetts Eye and Ear collaborators in Europe. Programs emphasize biomarker discovery using platforms pioneered by groups at the Max Planck Society and computational methods influenced by work at the European Bioinformatics Institute. Training fellowships link young investigators to laboratories at the University of Edinburgh and the VIB research institute.

Education and Outreach

Educational initiatives include continuing medical education courses held in cities like Vienna, Lisbon, and Prague in partnership with societies such as the European Society of Retina Specialists and the European Board of Ophthalmology. Outreach campaigns target aging populations in collaboration with NGOs including Age Platform Europe and advocacy groups like the Macular Society, and they have produced patient materials informed by guidelines from the National Health Service (England) and the World Health Organization. Public lectures have been hosted alongside museums and universities including Trinity College Dublin and Sorbonne University, and the Foundation participates in health policy forums alongside representatives from the European Commission.

Funding and Governance

Funding streams comprise competitive grants, philanthropic donations from foundations such as the Wellcome Trust and the Bill & Melinda Gates Foundation (in broader vision initiatives), and industry-sponsored fellowships involving pharmaceutical companies headquartered in Basel and Zurich. Governance is overseen by a board composed of clinicians and scientists affiliated with institutions like Moorfields Eye Hospital, Charité – Universitätsmedizin Berlin, Imperial College London, and representatives from patient organizations including Macular Society. Financial reporting follows frameworks adopted by the European Commission for non-profit accountability and aligns with standards from the International Federation of Accountants.

Partnerships and Collaborations

The Foundation collaborates with universities, hospitals, industry partners, and international organizations. Academic partners include University of Milan, KU Leuven, Heidelberg University, and Uppsala University; clinical partners include St Thomas' Hospital and Hôpital Lariboisière; industry collaborations involve biotechnology firms in Cambridge (UK), Basel, and Munich; and international engagement extends to bodies such as the Organisation for Economic Co-operation and Development and the World Health Organization. It also aligns research priorities with initiatives from the European Research Council and multi-stakeholder consortia that partner with the European Medicines Agency.

Impact and Recognition

The Foundation's work has contributed to multicenter publications in journals where authors are affiliated with University of Oxford, Karolinska Institutet, Imperial College London, University College London, and University of Edinburgh, and its symposia have convened keynote speakers from institutions like Harvard Medical School and Stanford University. It has received acknowledgments from professional societies such as the Royal College of Ophthalmologists and citations in policy briefs by the European Commission and the World Health Organization. Awards and fellowships associated with the Foundation have supported researchers who later held positions at institutes including the Max Planck Society, Institut Pasteur, and the European Molecular Biology Laboratory.

Category:Medical research foundations in Europe